71 related articles for article (PubMed ID: 10895080)
1. On the cardiac contractile, electrophysiological and biochemical effects of endothall, a protein phosphatase inhibitor.
Bokník P; Vahlensieck U; Huke S; Knapp J; Linck B; Lüss H; Müller FU; Neumann J; Schmitz W
Pharmacology; 2000 Jul; 61(1):43-50. PubMed ID: 10895080
[TBL] [Abstract][Full Text] [Related]
2. On the cardiac contractile, biochemical and electrophysiological effects of cantharidin, a phosphatase inhibitor.
Neumann J; Herzig S; Boknik P; Apel M; Kaspareit G; Schmitz W; Scholz H; Tepel M; Zimmermann N
J Pharmacol Exp Ther; 1995 Jul; 274(1):530-9. PubMed ID: 7616441
[TBL] [Abstract][Full Text] [Related]
3. Contractility and inhibition of protein phosphatases by cantharidin.
Knapp J; Bokník P; Huke S; Gombosová I; Linck B; Lüss H; Müller FU; Müller T; Nacke P; Schmitz W; Vahlensieck U; Neumann J
Gen Pharmacol; 1998 Nov; 31(5):729-33. PubMed ID: 9809469
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and electrophysiological mechanisms of the positive inotropic effect of calyculin A, a protein phosphatase inhibitor.
Neumann J; Bokník P; Herzig S; Schmitz W; Scholz H; Wiechen K; Zimmermann N
J Pharmacol Exp Ther; 1994 Oct; 271(1):535-41. PubMed ID: 7965753
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of the contractile effects of 2,3-butanedione-monoxime in the mammalian heart.
Zimmermann N; Boknik P; Gams E; Gsell S; Jones LR; Maas R; Neumann J; Scholz H
Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):431-6. PubMed ID: 8897445
[TBL] [Abstract][Full Text] [Related]
6. Evidence for physiological functions of protein phosphatases in the heart: evaluation with okadaic acid.
Neumann J; Boknik P; Herzig S; Schmitz W; Scholz H; Gupta RC; Watanabe AM
Am J Physiol; 1993 Jul; 265(1 Pt 2):H257-66. PubMed ID: 8393625
[TBL] [Abstract][Full Text] [Related]
7. Protein phosphatase 2A and its [3H]cantharidin/[3H]endothall thioanhydride binding site. Inhibitor specificity of cantharidin and ATP analogues.
Li YM; Mackintosh C; Casida JE
Biochem Pharmacol; 1993 Oct; 46(8):1435-43. PubMed ID: 8240393
[TBL] [Abstract][Full Text] [Related]
8. Endothall thioanhydride inhibits protein phosphatases-1 and -2A in vivo.
Erdödi F; Tóth B; Hirano K; Hirano M; Hartshorne DJ; Gergely P
Am J Physiol; 1995 Nov; 269(5 Pt 1):C1176-84. PubMed ID: 7491907
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of protein phosphatase activities in preparations from failing human hearts.
Neumann J; Maas R; Bokník P; Jones LR; Zimmermann N; Scholz H
J Pharmacol Exp Ther; 1999 Apr; 289(1):188-93. PubMed ID: 10087003
[TBL] [Abstract][Full Text] [Related]
10. Cantharidin-binding protein: identification as protein phosphatase 2A.
Li YM; Casida JE
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11867-70. PubMed ID: 1334551
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory action of the phosphatase inhibitor cantharidin on the endothelin-1-induced and the carbachol-induced negative inotropic effect in the canine ventricular myocardium.
Chu L; Norota I; Ishii K; Endoh M
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S89-92. PubMed ID: 12688404
[TBL] [Abstract][Full Text] [Related]
12. Cantharidin enhances norepinephrine-induced vasoconstriction in an endothelium-dependent fashion.
Knapp J; Bokník P; Linck B; Lüss H; Müller FU; Petertönjes L; Schmitz W; Neumann J
J Pharmacol Exp Ther; 2000 Aug; 294(2):620-6. PubMed ID: 10900240
[TBL] [Abstract][Full Text] [Related]
13. Role of protein phosphatases in regulation of cardiac inotropy and relaxation.
Bokník P; Khorchidi S; Bodor GS; Huke S; Knapp J; Linck B; Lüss H; Müller FU; Schmitz W; Neumann J
Am J Physiol Heart Circ Physiol; 2001 Feb; 280(2):H786-94. PubMed ID: 11158978
[TBL] [Abstract][Full Text] [Related]
14. Inotropic effects of diadenosine tetraphosphate (AP4A) in human and animal cardiac preparations.
Vahlensieck U; Bokník P; Gombosová I; Huke S; Knapp J; Linck B; Lüss H; Müller FU; Neumann J; Deng MC; Scheld HH; Jankowski H; Schlüter H; Zidek W; Zimmermann N; Schmitz W
J Pharmacol Exp Ther; 1999 Feb; 288(2):805-13. PubMed ID: 9918592
[TBL] [Abstract][Full Text] [Related]
15. Relationship between biochemical and functional effects of protein phosphatase 1 inhibitors in rabbit cardiac skinned fibers.
Berrebi-Bertrand I; Brument-Larignon N; Camelin JC; Quiniou MJ; Bril A
J Mol Cell Cardiol; 1998 Oct; 30(10):1945-54. PubMed ID: 9799649
[TBL] [Abstract][Full Text] [Related]
16. Calcium-independent activation of the contractile apparatus in smooth muscle of mouse aorta by protein phosphatase inhibition.
Knapp J; Aleth S; Balzer F; Schmitz W; Neumann J
Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):562-9. PubMed ID: 12444498
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of action of cantharidin in smooth muscle.
Knapp J; Bokník P; Huke S; Lüss H; Müller FU; Müller T; Nacke P; Schmitz W; Vahlensieck U; Neumann J
Br J Pharmacol; 1998 Mar; 123(5):911-9. PubMed ID: 9535020
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma cell lines from diethylnitrosamine phenobarbital-treated rats. Characterization and sensitivity to endothall, a protein serine/threonine phosphatase-2A inhibitor.
Thièry JP; Blazsek I; Legras S; Marion S; Reynes M; Anjo A; Adam R; Misset JL
Hepatology; 1999 May; 29(5):1406-17. PubMed ID: 10216123
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of the contractile effects of levosimendan in the mammalian heart.
Bokník P; Neumann J; Kaspareit G; Schmitz W; Scholz H; Vahlensieck U; Zimmermann N
J Pharmacol Exp Ther; 1997 Jan; 280(1):277-83. PubMed ID: 8996207
[TBL] [Abstract][Full Text] [Related]
20. Effects of novel pyridothiazepines and pyridothiazines on contractility of isolated guinea-pig heart muscle and vascular smooth muscle preparations.
Schade B; Studenik C
Biol Pharm Bull; 1999 Jul; 22(7):683-6. PubMed ID: 10443462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
